Trial Profile
Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia Treated With Clozapine and Olanzapine And Potential Effects on Cognitive Function.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Dec 2017
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary)
- Indications Dyslipidaemias; Glucose intolerance
- Focus Therapeutic Use
- 27 Apr 2010 Actual end date added as Jan 2010 as reported by clinicaltrials.gov.
- 27 Apr 2010 Status changed from recruiting to completed as reported by clinicaltrials.gov.
- 23 Jul 2008 New trial record.